Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease...
Alzheimer's DiseaseCentral Nervous System Diseases1 moreThis study is being conducted to determine the safety and effect on cognitive function of the investigational medication, EVP-6124, in individuals with mild to moderate probable Alzheimer's disease.
A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety,...
Alzheimer's DiseaseHuntington's DiseaseThis study is to compare the pharmacokinetics of Dimebon in subjects with severe renal impairment to subjects with normal renal function after oral administration of a single oral 20-mg dose of Dimebon. This study is also to assess the safety and tolerability of a single oral 20-mg dose of Dimebon in subjects with severe renal impairment and subjects with normal renal function.
Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease
Alzheimer's DiseaseThis study will investigate the ability of ST101 to improve memory in people with Alzheimer's disease. This study also will examine the safety and tolerability of the drug. This study is evaluating 3 different dose levels of ST101 and placebo. Patients will have a 1 in 4 chance of getting placebo.
A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients...
Alzheimer DiseaseVascular DementiaThe purpose of this study is to evaluate the safety and efficacy of galantamine (a drug for treating dementia) compared to placebo in the treatment of patients with dementia related to cerebrovascular disease (vascular dementia) or dementia related to Alzheimer's disease with cerebrovascular disease ("mixed" dementia).
Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and...
Alzheimer DiseaseDementiaThe purpose of this study is to evaluate the safety and effectiveness of a once daily controlled-release form of galantamine (a drug for treating dementia) versus placebo in the treatment of patients with Alzheimer's disease.
A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the...
Alzheimer DiseaseDementiaThe purpose of this study is to evaluate the safety and effectiveness of galantamine (a drug for treating dementia) versus placebo in the treatment of patients with Alzheimer's disease using a flexible dose design.
Escitalopram Treatment of Patients With Agitated Dementia
Alzheimer's DiseasePsychomotor AgitationThe purpose of this study is to determine the safety and efficacy of escitalopram (Lexapro) using 10 or 20 mg daily in patients with Alzheimer's disease who are also experiencing agitation.
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
Alzheimer's DiseaseThis is a placebo-controlled study evaluating the effects of rosiglitazone on functional brain activity and cognition in patients with mild to moderate Alzheimer's Disease (AD).
Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide...
DementiaAlzheimer DiseaseThe purpose of this study is to assess the effectiveness and safety of galantamine hydrobromide treatment in patients with severe Alzheimer's disease.
A Comparison of Two Standard Therapies in the Management of Dementia With Agitation
Senile DementiaAlzheimer Type4 moreThe purpose of this study is to determine whether an antipsychotic medication alone or an antipsychotic medication in combination with divalproex is the most effective and safest way to treat agitation in elderly patients with dementia.